Skip to main content
News & Announcements , Artificial Intelligence

Balancing Human Expertise and Artificial Intelligence in Drug Development

In this pharmaphorum article, Andy Lewis explores how artificial intelligence is transforming pharmaceutical development and why the most effective approach combines advanced algorithms with human scientific expertise.

Why Drug Development Needs Scientists and AI Working Together

Drawing on experience in formulation science and AI-enabled development, he discusses the opportunities AI creates for accelerating decision-making, reducing experimental burden, and uncovering valuable insights, while highlighting the critical role of scientists in providing oversight, context, and regulatory confidence throughout the drug development process.

Read the full article on Pharma Phorum website here.

Latest news from Quotient Sciences

More News
News & Announcements, Artificial Intelligence, Translational Pharmaceutics®, Formulation Development Quotient Sciences shortlisted for "Best Use of AI in Clinical Development & Trial Innovation" at the Scrip Awards 2026 By: Dr. Andrew Lewis
Read More
News & Announcements, Nottingham, UK, Artificial Intelligence, Translational Pharmaceutics®, Formulation Development Quotient Sciences Proprietary AI-Enhanced Solution Optimizes Formulation in Clinical Study By: Dr. Andrew Lewis
Read More
Let's Talk
Your breakthrough therapy deserves momentum, and every day matters. Start a conversation with us today.